Karabulut N (2015) Gadolinium deposition in the brain: another concern regarding gadolinium-based contrast agents. Diagn Interv Radiol 21:269–270
Article
PubMed
PubMed Central
Google Scholar
Kanda T, Oba H, Toyoda K (2016) Recent advances in understanding gadolinium retention in the brain. AJNR Am J Neuroradiol 37:E1–E2
CAS
Article
PubMed
Google Scholar
Kanda T, Ishii K, Kawaguchi H et al (2014) High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology 270:834–841
Article
PubMed
Google Scholar
Quattrocchi CC, Mallio CA, Errante Y et al (2015) Gadodiamide and dentate nucleus T1 hyperintensity in patients with meningioma evaluated by multiple follow-up contrast-enhanced magnetic resonance examinations with no systemic interval therapy. Invest Radiol 50:470–472
Article
PubMed
Google Scholar
Errante Y, Cirimele V, Mallio CA et al (2014) Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Invest Radiol 49:685–690
CAS
Article
PubMed
Google Scholar
Adin ME, Kleinberg L, Vaidya D et al (2015) Hyperintense dentate nuclei on T1-weighted MRI: relation to repeat Gadolinium administration. AJNR Am J Neuroradiol 36:1859–1865
CAS
Article
PubMed
PubMed Central
Google Scholar
McDonald RJ, McDonald JS, Kallmes DF et al (2015) Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 275:772–782
Article
PubMed
Google Scholar
Kanda T, Fukusato T, Matsuda M et al (2015) Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy. Radiology 276:228–232
Article
PubMed
Google Scholar
Radbruch A, Weberling LD, Kieslich PJ et al (2015) Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology 275:783–791
Article
PubMed
Google Scholar
Kanda T, Osawa M, Oba H et al (2015) High signal intensity in dentate nucleus on unenhanced T1-weighted MR images: association with linear versus macrocyclic gadolinium chelate administration. Radiology 275:803–809
Article
PubMed
Google Scholar
Ramalho J, Castillo M, AlOBaidy M et al (2015) High signal intensity in globus pallidus and dentate nucleus on unenhanced T1-weighted MR images: evaluation of two linear Gadolinium-based contrast agents. Radiology 276:836–844
Article
PubMed
Google Scholar
Stojanov DA, Aracki-Trenkic A, Vojinovic S et al (2015) Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, Gadobutrol. Eur Radiol 26:807–815
Article
PubMed
Google Scholar
Robert P, Lehericy S, Grand S et al (2015) T1-weighted hypersignal in the deep cerebellar nuclei after repeated administrations of Gadolinium-based contrast agents in healthy rats: difference between linear and macrocyclic agents. Invest Radiol 50:473–480
CAS
Article
PubMed
PubMed Central
Google Scholar
Wáng Y, Schroeder J, Siegmund H et al (2015) Total gadolinium tissue deposition and skin structural findings following the administration of structurally different gadolinium chelates in healthy and ovariectomized female rats. Quant Imaging Med Surg 5:534–545
PubMed
PubMed Central
Google Scholar
Roberts DR, Holden KR (2015) Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast. Brain Dev 38:331–336
Article
PubMed
Google Scholar
Miller JH, Hu HH, Pokorney A et al (2015) MRI brain signal intensity changes of a child during the course of 35 Gadolinium contrast examinations. Pediatrics 136:e1637–e1640
Article
PubMed
Google Scholar
Sato T, Tamada T, Watanabe S et al (2015) Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS). Radiol Med 120:557–562
Article
PubMed
Google Scholar
Huckle JE, Atlun E, Jay M et al (2016) Gadolinium deposition in humans: when did we learn that gadolinium was deposited in vivo? Invest Radiol 51:236–240
CAS
Article
PubMed
Google Scholar
Reeder SB, Gulani V (2016) Gadolinium deposition in the brain: do we know enough to change practice? Radiology 279:323–326
Article
PubMed
Google Scholar
Malayeri AA, Brooks KM, Bryant LH et al (2016) National Institutes of Health perspective on reports of gadolinium deposition in the brain. J Am Coll Radiol 13:237–241
Article
PubMed
Google Scholar
Radbruch A, Weberling LD, Kieslich PJ et al (2015) High-signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evaluation of the macrocyclic gadolinium-based contrast agent Gadobutrol. Invest Radiol 50:805–810
CAS
Article
PubMed
Google Scholar
Murata N, Gonzalez-Cuyar LF, Murata K et al (2016) Macrocyclic and other non-group 1 gadolinium contrast agents deposit low levels of gadolinium in brain and bone tissue: preliminary results from 9 patients with normal renal function. Invest Radiol. doi:10.1097/RLI.0000000000000252